Suchergebnis | Hamburg Open Science

Facetten

49 Einträge gefunden

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
2020 - Forschungsinformationssystem des UKE
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy
2017 - Forschungsinformationssystem des UKE
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy
2017 - Forschungsinformationssystem des UKE
Salvage Radical Prostatectomy for recurrent Prostate Cancer: Verification of EAU guideline criteria
2015 - Forschungsinformationssystem des UKE
A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy
2014 - Forschungsinformationssystem des UKE
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
2013 - Forschungsinformationssystem des UKE
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.
2012 - Forschungsinformationssystem des UKE
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
2012 - Forschungsinformationssystem des UKE
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy
2012 - Forschungsinformationssystem des UKE
Circulating miRNAs are correlated with tumor progression in prostate cancer.
2011 - Forschungsinformationssystem des UKE
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
2011 - Forschungsinformationssystem des UKE
Full functional-length urethral sphincter preservation during radical prostatectomy.
2011 - Forschungsinformationssystem des UKE
The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.
2010 - Forschungsinformationssystem des UKE
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.
2009 - Forschungsinformationssystem des UKE
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
2009 - Forschungsinformationssystem des UKE
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
2009 - Forschungsinformationssystem des UKE
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy

Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy

High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy

Salvage Radical Prostatectomy for recurrent Prostate Cancer: Verification of EAU guideline criteria

A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy

Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.

The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy

Circulating miRNAs are correlated with tumor progression in prostate cancer.

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

Full functional-length urethral sphincter preservation during radical prostatectomy.

The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.

Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.

Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.

[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.

Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.